Prognostication in acute liver failure: A tool or an anchor?

Liver Transplantation

Volumn 13, Issue 6, 2007, Pages 786-787

  O'Grady, John G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; PARACETAMOL;

AGE; BILIRUBIN BLOOD LEVEL; BRAIN EDEMA; CREATININE BLOOD LEVEL; EDITORIAL; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SCORING SYSTEM; VIRUS HEPATITIS;

HUMANS; LIVER FAILURE, ACUTE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 34250634827     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21159     Document Type: Editorial

References (9)

1. O'Grady JG, Alexander GJ, Hallyar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
2. Wiesner RH. MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis and acute Wilson's disease. Liver Transpl 2004;10:S17-S22.
3. Yantorno SET, Trentadue JJ, Ruf AE, Saa G, Descalzi VI, Andriani OC, et al. The Model for End-Stage Liver Disease (MELD): a useful tool to access prognosis in fulminant hepatic failure. Liver Transpl 2004;10:C36.
4. Dhiman R, Jain S, Maheswari U, Bhalla A, Navneet S, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the MELD and King's College Hospital criteria. Liver Transpl 2007;13: 814-821.
5. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988;94:1186-1192.
6. Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, et al., U.S. Acute Failure Study Group. Fulminant hepatitis A virus infection in the United States: incidence, prognosis and outcomes. Hepatology 2006;44:1589-1597.
7. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al., Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multi-center, prospective study. Hepatology 2005;42:1364-1372.
8. Yantorno S, Kremers W, Ruf A, Trentadue J, Podesta L, Villamil FG. MELD is superior to King's College and Clichy criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007;13:822-828.
9. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986;6:648-651.